Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cullinan Therapeutics

8.79
+0.27003.17%
Post-market: 8.790.00000.00%16:20 EDT
Volume:396.78K
Turnover:3.50M
Market Cap:514.33M
PE:-2.82
High:8.97
Open:8.56
Low:8.50
Close:8.52
Loading ...
Dec 29, 2021

Major Issues Report

8-K - Current report
Dec 20, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2021

Major Issues Report

8-K - Current report
Oct 20, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 20, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 20, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 04, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Major Issues Report

8-K - Current report
Feb 26, 2021

Major Issues Report

8-K - Current report
Feb 22, 2021

Major Issues Report

8-K - Current report